Characterization of Proteins Associated with Polyglutamine Aggregates

References

• Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000; 23:217 - 247
   PubMed Web of Science ®Google Scholar
• Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997; 90:537 - 548
   PubMed Web of Science ®Google Scholar
• DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997; 277:1990 - 1993
   PubMed Web of Science ®Google Scholar
• Perez-Navarro E, Canals JM, Gines S, Alberch J. Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease. Histol Histopathol 2006; 21:1217 - 1232
   PubMed Web of Science ®Google Scholar
• Chen S, Berthelier V, Yang W, Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J Mol Biol 2001; 311:173 - 182
   PubMed Web of Science ®Google Scholar
• Preisinger E, Jordan BM, Kazantsev A, Housman D. Evidence for a recruitment and sequestration mechanism in Huntington's disease. Philos Trans R Soc Lond B Biol Sci 1999; 354:1029 - 1034
   PubMed Web of Science ®Google Scholar
• Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002; 416:507 - 511
   PubMed Web of Science ®Google Scholar
• Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J Mol Med 2003; 81:678 - 699
   PubMed Web of Science ®Google Scholar
• Buxbaum JN. Diseases of protein conformation: What do in vitro experiments tell us about in vivo diseases?. Trends Biochem Sci 2003; 28:585 - 592
   PubMed Web of Science ®Google Scholar
• Gutekunst CA, Li SH, Yi H, Ferrante RJ, Li XJ, Hersch SM. The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): Comparison with huntingtin in rat and human. J Neurosci 1998; 18:7674 - 7686
   PubMed Web of Science ®Google Scholar
• Huntington JL, Stratton DM, Scattergood TW. Exobiology research on space station freedom. Adv Space Res 1995; 15:135 - 138
   PubMed Web of Science ®Google Scholar
• Doi H, Mitsui K, Kurosawa M, Machida Y, Kuroiwa Y, Nukina N. Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates. FEBS Lett 2004; 571:171 - 176
   PubMed Web of Science ®Google Scholar
• Suhr ST, Senut MC, Whitelegge JP, Faull KF, Cuizon DB, Gage FH. Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J Cell Biol 2001; 153:283 - 294
   PubMed Web of Science ®Google Scholar
• Mitsui K, Nakayama H, Akagi T, Nekooki M, Ohtawa K, Takio K, Hashikawa T, Nukina N. Purification of polyglutamine aggregates and identification of elongation factor-1alpha and heat shock protein 84 as aggregate-interacting proteins. J Neurosci 2002; 22:9267 - 9277
   PubMed Web of Science ®Google Scholar
• Meriin AB, Mabuchi K, Gabai VL, Yaglom JA, Kazantsev A, Sherman MY. Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1. J Cell Biol 2001; 153:851 - 864
   PubMed Web of Science ®Google Scholar
• Meriin AB, Zhang X, He X, Newnam GP, Chernoff YO, Sherman MY. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol 2002; 157:997 - 1004
   PubMed Web of Science ®Google Scholar
• Yates IIIrd JR. Mass spectrometry: From genomics to proteomics. Trends Genet 2000; 16:5 - 8
   PubMed Web of Science ®Google Scholar
• Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003; 422:198 - 207
   PubMed Web of Science ®Google Scholar
• Zubarev R, Mann M. On the proper use of mass accuracy in proteomics. Mol Cell Proteomics 2007; 6:377 - 381
   PubMed Web of Science ®Google Scholar
• Zhang W, Chait BT. ProFound: An expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem 2000; 72:2482 - 2489
   PubMed Web of Science ®Google Scholar
• Burke JR, Enghild JJ, Martin ME, Jou YS, Myers RM, Roses AD, Vance JM. Strittmatter WJ, Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 1996; 2:347 - 350
   PubMed Web of Science ®Google Scholar
• Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet 1996; 5:1311 - 1318
   PubMed Web of Science ®Google Scholar
• Huh WK, Falvo JV, Gerke LC, Carroll AS, Howson RW, Weissman JS, O'Shea EK. Global analysis of protein localization in budding yeast. Nature 2003; 425:686 - 691
   PubMed Web of Science ®Google Scholar
• Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 1995; 268:880 - 884
   PubMed Web of Science ®Google Scholar
• Krobitsch S, Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci USA 2000; 97:1589 - 1594
   PubMed Web of Science ®Google Scholar
• Osherovich LZ, Weissman JS. Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI+] prion. Cell 2001; 106:183 - 194
   PubMed Web of Science ®Google Scholar
• Motoyama A, Venable JD, Ruse CI, Yates JR IIIrd. Automated ultra-high-pressure multidimensional protein identification technology (UHP-MudPIT) for improved peptide identification of proteomic samples. Anal Chem 2006; 78:5109 - 5118
   PubMed Web of Science ®Google Scholar
• Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335:924 - 930
   PubMed Web of Science ®Google Scholar
• Emamian ES, Kaytor MD, Duvick LA, Zu T, Tousey SK, Zoghbi HY, Clark HB, Orr HT. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 2003; 38:375 - 377
   PubMed Web of Science ®Google Scholar
• Chen HK, Fernandez-Funez P, Acevedo SF, Lam YC, Kaytor MD, Fernandez MH, Aitken A, Skoulakis EM, Orr HT, Botas J, Zoghbi HY. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 2003; 113:457 - 468
   PubMed Web of Science ®Google Scholar
• Bailleul PA, Newnam GP. Steenbergen JN, Chernoff YO, Genetic study of interactions between the cytoskeletal assembly protein sla1 and prion-forming domain of the release factor Sup35 (eRF3) in Saccharomyces cerevisiae. Genetics 1999; 153:81 - 94
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Uptain SM, Outeiro TF, Krishnan R, Lindquist SL, Liebman SW. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc Natl Acad Sci USA 2004; 101:12934 - 12939
   PubMed Web of Science ®Google Scholar